See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says.

Posted on AllSides November 16th, 2020
From The Left

A second COVID-19 candidate vaccine looks to be even more effective than the first, with both protecting more than 90% of those who get the shots.

Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease.

Earlier this month, Pfizer and its German partner BioNTech, announced early effectiveness data, showing their vaccine, called BNT162b2, had protected more than 90% of those who received it.

Both results are preliminary, with final...

Read full story
Some content from this outlet may be limited or behind a paywall.

AllSides Picks

https://www.usatoday.com/story/news/nation/2020/11/16/moderna-covid-19-vaccine-trial-effective-candidate/6307647002/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right